Trial Profile
Phase IIb placebo-controlled, double-blind trial of fibroblast growth factor-1 [CVBT 141B] in patients with ischaemic diabetic ulcers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2020
Price :
$35
*
At a glance
- Drugs Fibroblast growth factor 1 (Primary)
- Indications Diabetic complications; Diabetic foot ulcer
- Focus Therapeutic Use
- 30 Apr 2014 New trial record